PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 233 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,720,811 | -36.0% | 95,100 | -34.6% | 0.21% | -36.3% |
| Q1 2024 | $4,248,588 | -6.0% | 145,400 | +8.5% | 0.34% | -8.9% |
| Q4 2023 | $4,521,160 | +552.4% | 134,000 | +636.3% | 0.37% | +504.9% |
| Q3 2019 | $693,000 | -12.5% | 18,200 | 0.0% | 0.06% | -22.8% |
| Q2 2019 | $792,000 | +40.7% | 18,200 | +23.0% | 0.08% | +54.9% |
| Q1 2019 | $563,000 | +23.5% | 14,800 | +39.6% | 0.05% | -5.6% |
| Q4 2018 | $456,000 | – | 10,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
| GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
| Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
| Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
| AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
| ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
| RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
| Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
| Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
| Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |